Update - patent litigation

Amphion Innovations plcUpdate - patent litigation

London and New York, 29 August 2012- Amphion Innovations plc (LSE: AMP) ("Amphion" or the "Company"), the developer of medical and technology businesses, announces that the United States District Court for the Southern District of New York issued its ruling concerning the construction of certain claim terms in the 402 and 502 patents. DataTern is reviewing the ruling in these complex cases, conferring with counsel and considering all of its strategic options. DataTern continues to believe that these patents are valid and have been infringed.

For further information please contact:

Amphion Innovations

Charlie Morgan

+1 212 210 6224

Cardew Group

Tim Robertson

+44 (0)20 7930 0777

Seymour Pierce Limited, Nominated Advisor

Mark Percy/Catherine Leftley

+44 (0)20 7107 8000